|1||Not yet recruiting||
TEW-7197 in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors
|3||Not yet recruiting||
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
† Study has passed its completion date and status has not been verified in more than two years.